https://bmcpublichealth.biomedcentral.com/articles/10.1186/s12889-023-17052-1
0
0
Cost-effectiveness analysis of antiretroviral drugs for treatment-naive HIV infection in China - BMC Public Health - BMC Public Health
+ 125 more
11/13/23 at 2:55am
Organization
Biomedcentral.com
Authors
Details
60 words
Summarize
AIDS & HIV Infectious Diseases Reproductive Health Health China formulary BMC Public Health National Free Antiretroviral Treatment Program
Introduction Dolutegravir (DTG)-based regimen was included in the expanded formulary of China's National Free Antiretroviral Treatment Program at the end of 2021. Yet high price of DTG and lack of health economic evaluation in China present barriers for imple…
Create an account or login to join the discussion